CARTX THERAPEUTICS
Live / Applied — Statement of use — processing complete, to examiner (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 07 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98841635
- Mark type
- Stylized text
- Filed
- 07 Nov 2024
- Published for opposition
- 13 May 2025
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancers and autoimmune diseases; Pharmaceutical preparations for the treatment of cancers and autoimmune diseases
Owner
- CARTx Therapeutics Corp., Hopkinton, MA, US
- CARTx Therapeutics Corp., Hopkinton, MA, US
Prosecution history
- 26 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Aug 2025 — USE AMENDMENT FILED
- 26 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 May 2025 — PUBLISHED FOR OPPOSITION
- 07 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Apr 2025 — ASSIGNED TO EXAMINER
- 07 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Nov 2024 — NEW APPLICATION ENTERED